Articles by Rachel Lutz

Latest Articles

Could Cadazolid be the Next Breakthrough in C. difficile Treatment?
  |  Rachel Lutz
Researchers may have stumbled upon a potential new treatment for C. difficile.
Gastric Acid Suppressants Impact C. difficile Recurrence Risk
  |  Rachel Lutz
Patients with C. difficile are urged to avoid gastric acid suppressants.
Long-Term Care Facilities Vs. Community Homes: Which Have Higher Rates of Severe C. difficile?
  |  Rachel Lutz
Why do some patient care settings have higher rates of C. difficile infection?
What is the Most Cost Effective C. difficile Treatment?
  |  Rachel Lutz
Researchers studied the costs associated with various C. difficile treatments.
C. difficile Potentially Dangerous for Colorectal Cancer Patients
  |  Rachel Lutz
Patients with preoperative colorectal cancer have reported high incidence rates of C. difficile.
Can FMT be a Successful Pediatric IBD Treatment?
  |  Rachel Lutz
Researchers explore whether FMT is safe for children with IBD.
Hospital Room Floors Often Contaminated with Pathogens
  |  Rachel Lutz
Patients’ hospital room floors are frequently contaminated with pathogens.
Don't Count Elderly Patients Out as FMT Donors
  |  Rachel Lutz
Age doesn't appear to impact FMT as long as donors are healthy.
What Types of Patients Will Accept FMT as C. difficile Treatment?
  |  Rachel Lutz
Researcher questioned variables that prevent C. diff patients from getting FMT.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$